Year to date through September 2025, the FDA’s list of AI-enabled device authorizations included more than 250 devices, with Radiology taking the lead.

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...

So, you need a heavy-duty pickup truck, and have decided on something that adorns the legendary Blue Oval badge. However, Ford offers two compelling engine options, and you're not sure which direction ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories is moving to replace more than a ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors showed they ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

While it’s no secret that bitcoin has been falling fast, investors in Strategy may be surprised at how much farther the cryptocurrency stockpiler’s shares have dropped in recent weeks and months. Tomi ...

The iPhone 17 series has redefined expectations for modern smartphones, offering a blend of advanced technology and user-centric design. While the base iPhone 17 introduces features that were ...